CEL-SCI Receives Regulatory Clearance To Expand Phase III Head And Neck Cancer Trial Into Turkey
July 22, 2014 at 08:35 AM EDT
CEL-SCI Corporation (NYSE MKT: CVM) today announced that Turkey's Ministry of Health has cleared the company to begin patient ...